SCHEMBL19628178

SCHEMBL19628178

c1ccc(-c2cc3c4ccccc4c(-c4cc5cccc6c7c8ccccc8sc7c7cccc4c7c56)cc3c3ccccc23)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.35
KMT2A Q03164 5/20 0.35
ALDH1A1 P00352 5/20 0.35
KDM4E B2RXH2 5/20 0.35
HPGD P15428 4/20 0.35
MAPT P10636 3/20 0.35
MPI P34949 1/20 0.35
TNKS O95271 2/20 0.35
TNKS2 Q9H2K2 2/20 0.35
F9 P00740 1/20 0.35
ALOX5 P09917 1/20 0.35
LIMK1 P53667 1/20 0.33
CYP1A1 P04798 1/20 0.33
CYP1B1 Q16678 1/20 0.33
CYP11B1 P15538 1/20 0.33
PTPN1 P18031 1/20 0.32
CYP1A2 P05177 2/20 0.32
HSD17B10 Q99714 2/20 0.32
THRB P10828 1/20 0.32
SLC9A1 P19634 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19628140 0.95 MEN1 (0.38) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL19628180 0.94 TNKS (0.33) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL19628179 0.89 ALOX5 (0.38) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL19628176 0.88 CYP1A2 (0.41) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL19628146 0.88 TNKS (0.35) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL19628171 0.88 ALOX5 (0.35) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL19628172 0.88 ALDH1A1 (0.41) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL19628168 0.87 F9 (0.39) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL19628185 0.85 ALOX5 (0.41) ALDH1A1HPGDTNKSTNKS2F9
SCHEMBL19628175 0.84 PTPN1 (0.37) MEN1KMT2AALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10439144-B2 Organic compound for electronic device comprising fused-core structure, organic optoelectronic device comprising same, and display device UNIVERSITY-INDUSTRY COOPERATEON GROUP OF KYUNG HEE UNIVERSITY (KR) 2019-10-08 US disclosed
US-20170338416-A1 ORGANIC COMPOUND FOR ELECTRONIC DEVICE COMPRISING FUSED-CORE STRUCTURE, ORGANIC OPTOELECTRONIC DEVICE COMPRISING SAME, AND DISPLAY DEVICE UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY (KR) 2017-11-23 US disclosed
US-20170338416-A1 ORGANIC COMPOUND FOR ELECTRONIC DEVICE COMPRISING FUSED-CORE STRUCTURE, ORGANIC OPTOELECTRONIC DEVICE COMPRISING SAME, AND DISPLAY DEVICE UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY (KR) 2017-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10439144-B2 Organic compound for electronic device comprising fused-core structure, organic optoelectronic device comprising same, and display device OR10J3, OCIAD2, OCIAD1 MEN1 1867/4885KMT2A 3182/4885ALDH1A1 105/4885
US-20170338416-A1 ORGANIC COMPOUND FOR ELECTRONIC DEVICE COMPRISING FUSED-CORE STRUCTURE, ORGANIC OPTOELECTRONIC DEVICE COMPRISING SAME, AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 MEN1 1867/4885KMT2A 3182/4885ALDH1A1 105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.